Ignite Creation Date:
2024-05-06 @ 2:16 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04262804
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-22
First Post:
2020-01-30
Brief Title:
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2 MBC
Sponsor:
Zai Lab Shanghai Co Ltd
Organization:
Zai Lab Hong Kong Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-30
First Submit QC Date:
February 6 2020
Study First Post Date:
2020-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-21
Last Update Post Date:
2023-08-22
Last Update Post Date Type:
ACTUAL